Loading clinical trials...
Loading clinical trials...
Neurocognitive Testing in Long COVID and Postural Tachycardia Syndrome Patients with Normal Saline: a Pilot Study
Conditions
Interventions
IV normal saline (999 mL infusion)
IV normal saline (50 mL infusion)
Locations
1
Canada
University of Calgary
Calgary, Alberta, Canada
Start Date
September 19, 2024
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2029
Last Updated
March 27, 2025
NCT05212129
NCT06593600
NCT07196397
NCT06616363
NCT06936319
NCT05877534
Lead Sponsor
University of Calgary
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions